Related Experiment Video

Updated: Jun 10, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

A new distal myopathy with mutation in anoctamin 5

Ibrahim Mahjneh1, Jyoti Jaiswal, Antti Lamminen

  • 1Department of Neurology, Oulu University Hospital, Oulu, Finland; Department of Neurology, Pietarsaari Central Hospital, Pietarsaari, Finland. ibrahim.mahjneh@mhso.fi

Neuromuscular Disorders : NMD
|August 10, 2010
PubMed

Insights

This study identifies anoctamin 5 (ANO5) as the gene causing a new form of distal muscular dystrophy. The research highlights defective membrane repair as the cellular defect in this slow-progressing genetic muscle disorder.

Area of Science:

  • Neurology
  • Genetics
  • Cell Biology

Background:

  • Distal muscular dystrophies are a group of inherited muscle-wasting disorders.
  • Understanding the genetic basis of these conditions is crucial for diagnosis and treatment.

Observation:

  • A Finnish family with a unique distal muscular dystrophy was studied over 3 decades.
  • Patients presented with calf burning/tightness in their third decade, followed by asymmetric muscle weakness and wasting.
  • Muscle MRI revealed dystrophic changes, and biopsies showed sarcolemmal membrane disruption without inflammation.

Findings:

  • The causative gene for this specific distal muscular dystrophy was identified as anoctamin 5 (ANO5).
  • The primary cellular defect involves impaired membrane repair mechanisms.
  • High creatine kinase (CK) levels were consistently observed in affected individuals.

Implications:

  • This discovery establishes a new clinical, genetic, and histopathologic entity within autosomal recessive distal muscular dystrophies.
  • Identifying the ANO5 gene opens avenues for genetic counseling and potential therapeutic strategies.
  • Further research into ANO5 function may elucidate mechanisms underlying other muscular dystrophies.

More Related Videos

Functional Characterization of Endogenously Expressed Human RYR1 Variants07:59

Functional Characterization of Endogenously Expressed Human RYR1 Variants

Published on: June 9, 2021

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

Related Concept Videos

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Actin Polymerization and Cell Motility01:13

Actin Polymerization and Cell Motility

Actin is a family of globular proteins that are highly abundant in eukaryotic cells. It makes up approximately 1-5% of total cell protein concentration. Actin monomers polymerize to form a complex network of polarized filaments, the actin cytoskeleton, that plays a crucial role in many cellular processes, including cell motility, division, endocytosis, and metastasis of cancer cells.
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate.
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...